Herpes Zoster
194
19
32
132
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
64 trials with published results (33%)
Research Maturity
132 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
1.5%
3 terminated out of 194 trials
97.8%
+11.2% vs benchmark
36%
70 trials in Phase 3/4
48%
64 of 132 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 132 completed trials
Clinical Trials (194)
Clinical and Economic Impact of Herpes Zoster in Cancer Patients
Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over
Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine
A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland
Efficacy and Safety of High-Concentration 35 kDa Hyaluronan Gel for Herpes Zoster-Associated Pain
The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept
A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older
The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster
Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above
The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster
A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)
A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant
Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic Neuralgia
Postherpetic Neuralgia After Herpes Zoster and Incident Dementia Risk
Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine
Electroacupuncture Regulation of Immune Cells in Herpes Zoster
The Analgesic Efficacy and Safety of Baclofen in Patients With Herpes Zoster
The Analgesic Efficacy and Safety of Loxoprofen Sodium Patch in Patients With Herpes Zoster